On September 17, 2025, Co-Diagnostics, Inc. entered into an agreement to sell 9,619,000 shares of common stock at $0.40 each, raising approximately $3.8 million for working capital. The offering is expected to close on September 18, 2025.
AI Assistant
CO-DIAGNOSTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.